PCH
Polar Capital Holdings’s Celldex Therapeutics CLDX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $25M | Sell |
1,228,435
-175,000
| -12% | -$3.56M | 0.13% | 124 |
|
|
2025
Q1 | $25.5M | Sell |
1,403,435
-162,396
| -10% | -$2.95M | 0.16% | 132 |
|
|
2024
Q4 | $39.6M | Sell |
1,565,831
-1,155,046
| -42% | -$29.2M | 0.22% | 112 |
|
|
2024
Q3 | $92.5M | Sell |
2,720,877
-355,906
| -12% | -$12.1M | 0.44% | 51 |
|
|
2024
Q2 | $114M | Buy |
3,076,783
+17,291
| +0.6% | +$640K | 0.67% | 38 |
|
|
2024
Q1 | $128M | Sell |
3,059,492
-76,379
| -2% | -$3.21M | 0.67% | 33 |
|
|
2023
Q4 | $124M | Buy |
3,135,871
+709,115
| +29% | +$28.1M | 0.76% | 29 |
|
|
2023
Q3 | $66.8M | Buy |
2,426,756
+10,000
| +0.4% | +$275K | 0.49% | 57 |
|
|
2023
Q2 | $82M | Buy |
2,416,756
+148,767
| +7% | +$5.05M | 0.41% | 57 |
|
|
2023
Q1 | $81.6M | Buy |
2,267,989
+717,989
| +46% | +$25.8M | 0.53% | 53 |
|
|
2022
Q4 | $69.1M | Buy |
1,550,000
+101,066
| +7% | +$4.5M | 0.55% | 57 |
|
|
2022
Q3 | $40.7K | Buy |
1,448,934
+801,514
| +124% | +$22.5K | 0.26% | 89 |
|
|
2022
Q2 | $17.5K | Sell |
647,420
-602,580
| -48% | -$16.2K | 0.1% | 155 |
|
|
2022
Q1 | $42.6K | Buy |
1,250,000
+250,000
| +25% | +$8.52K | 0.19% | 101 |
|
|
2021
Q4 | $38.6K | Buy |
1,000,000
+277,157
| +38% | +$10.7K | 0.15% | 113 |
|
|
2021
Q3 | $39K | Buy |
722,843
+222,843
| +45% | +$12K | 0.16% | 112 |
|
|
2021
Q2 | $16.7K | Hold |
500,000
| – | – | 0.07% | 185 |
|
|
2021
Q1 | $10.3M | Sell |
500,000
-500,000
| -50% | -$10.3M | 0.06% | 203 |
|
|
2020
Q4 | $17.5M | Buy |
+1,000,000
| New | +$17.5M | 0.11% | 171 |
|